QINLOCK (ripretinib) for the Treatment of Gastrointestinal Stromal Tumour

Image 1-QINLOCK (ripretinib)
QINLOCK™ (ripretinib) is indicated for the treatment of advanced gastrointestinal stromal tumor (GIST). Credit: Deciphera Pharmaceuticals, Inc.